Assessing quality of life in cancer patients with skin conditions
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
This study looks at how skin problems related to cancer or its treatments affect the quality of life for cancer patients and survivors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1025 (estimated) |
| Ages | 3 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 4 sites (Basking Ridge, New Jersey and 3 other locations) |
| Trial ID | NCT02296450 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate how dermatologic conditions associated with cancer or its treatments impact the overall well-being of patients and survivors. Participants will complete questionnaires regarding their experiences with skin issues, both at the start and during follow-up visits if treatment is needed. The goal is to enhance understanding of the relationship between skin conditions and cancer, ultimately improving treatment approaches for affected patients.
Who should consider this trial
Good fit: Ideal candidates include cancer patients and survivors aged 3 years and older with pre-existing dermatologic conditions related to their cancer or its treatment.
Not a fit: Patients with cognitive or psychiatric deficits that prevent them from providing informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management and treatment strategies for skin conditions in cancer patients, improving their quality of life.
How similar studies have performed: While this approach is focused on quality of life assessments, similar studies have shown success in understanding the impact of dermatologic conditions on cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer patients and survivors with a pre-existing dermatologic condition related to their underlying disease or completed/ongoing therapy for cancer, who present for assessment/management of their skin condition. * Male or female patients at least 3 years and older * NOTE: Informed Consent guidelines will be followed for minors * First grade adult family members, spouses, and caregivers of patients with a Grade 2 or 3 or higher dermatologic condition related to their primary cancer or cancer treatment able to provide written informed consent Exclusion Criteria: * Cognitive or psychiatric deficit resulting in an inability to provide written informed consent
Where this trial is running
Basking Ridge, New Jersey and 3 other locations
- Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Westchester — Harrison, New York, United States (Recruiting)
- Memorial Sloan Kettering Suffolk- Hauppauge — Hauppauge, New York, United States (Recruiting)
- Memorial Sloan Kettering Cancer Center — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Erica Lee, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Erica Lee, MD
- Phone: 646-888-6015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.